The appropriate duration of anticoagulation for venous thromboembolism (VTE) in patients who have a transient provoking factor (e.g., surgery, trauma, or immobility) and concomitant enduring risk ...
In patients with active cancer and venous thromboembolism, whether extended treatment with a reduced dose of an oral anticoagulant is effective in preventing recurrent thromboembolic events and ...
MADRID, Spain—For patients who experience venous thromboembolism (VTE) provoked by surgery, immobility, or other factors and who face ongoing risk factors, 12 months of low-intensity apixaban (Eliquis ...
If you’re experiencing severe side effects from the blood thinner warfarin, a doctor may recommend an alternative known as non-vitamin K oral anticoagulants (NOACs). Non-vitamin K oral anticoagulants ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback